Overview
Short Course: October 22 | Virtual
Meeting: October 27-28 | In-Person
The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.
Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.
Participant Testimonials
Very meaningful topics, excellent speakers which allowed meaningful conversations. Size of the event also facilitates networking. - Véronique Lafrance, Senior Project Manager, Regulatory Affairs, Organon Canada
Amazing opportunity to meet PV and regulatory professionals from across Canada, learn about the challenges they face locally and in collaboration with their global affiliates. We enjoy being there every year! - Zenith PV – Exhibitor
The meeting presented a valuable learning opportunity, as we gained insights into best practices from different companies and heard the regulatory agency perspective. In addition to the professional development, DIA Canada 2024 provided an excellent networking platform to connect with peers and colleagues from across the industry and regulatory sphere. I really encourage others to join DIA's events and meetings in the future. - Vanessa Zapata, Associate Director, Regional Pharmacovigilance Officer, Merck Canada Inc.
Program Committee
-
Melanie Cote, MS Senior Manager, Global Regulatory Affairs
Otsuka Pharmaceutical Development & Commercialization Inc., Canada -
Marie-France Goyer, MSc Senior Director, Clinical Operations
Abcellera, Canada -
Nadia Latif, MS Senior Manager, Pharmacovigilance
Ipsen Biopharmaceuticals Canada Inc., Canada -
Hocine Abid, MD, MBA National Manager, Regulatory Operations and Enforcement Branch
Health Canada, Canada -
Stephanie Anderson, MS Associate Director, Regulatory Affairs
Intrinsik Corp., Canada -
Rebecca Barnes, MS Executive Director
Network of Networks (N2), Canada -
Katalin Bertenyi, MSc Manager, Centre for Blood, Blood Products and Biotherapeutics
Health Canada, Canada -
Louise Blythe, MSc Head, Regulatory Affairs
Bayer Inc. Canada, Canada -
Anna Bussel, MPharm Vice President Pharmacovigilance and Medical Information
ClaroPV Services Inc, Canada -
My Dang, MBA Director, Regulatory Affairs
Cencora, Canada -
Tharany Ganesh, MSc Head, Regulatory Affairs
AstraZeneca Canada Inc., Canada -
Daniel Greco, PharmD, MS, RPh Associate Director of Patient Safety
Bristol-Myers Squibb Company, Canada -
Yatika Kohli, PhD, MBA Chief Compliance and Strategy Officer
NoNO Inc, Canada -
Mei Lam, BSN, RN Associate Director Consumer Safety Regions Americas
Haleon, Canada -
Randy Levitt, PhD Director, Pharmacovigilance, Medical Information and Patient Support
Knight Therapeutics Inc., Canada -
Kim McDonald-Taylor, MS, MSc Clinical Research Consultant
Clinical Research Association of Canada Inc., Canada -
Amber McLeod, PhD Immunology, Virology, and Specialty Head, Regulatory Affairs
Abbvie Corporation, Canada -
Ricardo Pasquel Cook, MD Safety Team Lead
Pfizer Inc., Canada -
Sabrina Ramkellawan President and Board Director
Clinical Research Association of Canada, Canada -
Marcia Sam Senior Manager, Regulatory Affairs
Regeneron Canada Company, Canada -
Yulia Vasianovich, PhD, RAC Scientific Evaluator, Marketed Health Products Directorate
Health Canada, Canada
Have an account?